Seattle biotech CEO keeps a watchful eye on the market for potential IPO
Kineta Inc. CEO, Shawn Iadonato recently spoke to PSBJ about laying the groundwork for an IPO.
Iadonato told PSBJ’s Megan Campbell, “We’re really watching the capital markets closely. There’s been continued strength in the biotech sector relative to the other sectors, and we expect that will continue even despite the current environment.”